Literature DB >> 7517814

Cytokine control of nutrition and metabolism in critical illness.

W W Souba1.   

Abstract

During the last two decades, major advances in technology and in our fundamental understanding of the biologic aspects of sepsis and cancer cachexia have dramatically affected the therapeutic strategies available to the surgeon to care for critically ill patients. It is clear, however, that cytokines affect whole body nutrition and metabolism and are responsible for many of the clinically observed nutritional effects of injury, infection, and cancer, including fever, hypermetabolism, anorexia, protein catabolism, cachexia, and altered fat, glucose, and trace mineral metabolism. These metabolic and nutritional effects of cytokines are influenced by the nutritional status of the host, which is generally altered during the course of the critical illness. In the future, the use of specialized diets and the use of selective cytokine blockade are likely to be important components of the overall care of the catabolic patient.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7517814     DOI: 10.1016/0011-3840(94)90047-7

Source DB:  PubMed          Journal:  Curr Probl Surg        ISSN: 0011-3840            Impact factor:   1.909


  5 in total

1.  Glucocorticoid-dependent induction of interleukin-6 receptor expression in human hepatocytes facilitates interleukin-6 stimulation of amino acid transport.

Authors:  C P Fischer; B P Bode; K Takahashi; K K Tanabe; W W Souba
Journal:  Ann Surg       Date:  1996-05       Impact factor: 12.969

2.  [Nutrition of critically ill patients in intensive care].

Authors:  K G Kreymann; G de Heer; T Felbinger; S Kluge; A Nierhaus; U Suchner; R F Meier
Journal:  Internist (Berl)       Date:  2007-10       Impact factor: 0.743

Review 3.  Effect of dietary intake on immune function in athletes.

Authors:  Jaya T Venkatraman; David R Pendergast
Journal:  Sports Med       Date:  2002       Impact factor: 11.136

4.  Fatigue is associated with high circulating leptin levels in chronic hepatitis C.

Authors:  T Piche; E Gelsi; S M Schneider; X Hébuterne; J Giudicelli; B Ferrua; C Laffont; S Benzaken; P Hastier; M L Montoya; F Longo; P Rampal; A Tran
Journal:  Gut       Date:  2002-09       Impact factor: 23.059

5.  Serum hepatocyte growth factor as an index of disease status of patients with colorectal carcinoma.

Authors:  T Fukuura; C Miki; T Inoue; K Matsumoto; H Suzuki
Journal:  Br J Cancer       Date:  1998-08       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.